Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, et al.

N Engl J Med. 1992 Oct 29;327(18):1253-9.

4.
5.

A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.

Thal LJ, Schwartz G, Sano M, Weiner M, Knopman D, Harrell L, Bodenheimer S, Rossor M, Philpot M, Schor J, Goldberg A.

Neurology. 1996 Dec;47(6):1389-95.

PMID:
8960716
6.
7.

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B.

Neurology. 1998 May;50(5):1222-30.

PMID:
9595967
8.

A double-blind, placebo-controlled study of tacrine in Chinese patients with Alzheimer's disease.

Wong WJ, Liu HC, Fuh JL, Wang SJ, Hsu LC, Wang PN, Sheng WY.

Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):289-94.

PMID:
10364647
9.

Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease.

Schneider LS, Farlow MR, Henderson VW, Pogoda JM.

Neurology. 1996 Jun;46(6):1580-4.

PMID:
8649552
10.

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.

Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D.

J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):589-95.

12.

Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.

Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R; AWARE Study Group..

CNS Drugs. 2006;20(4):311-25. Erratum in: CNS Drugs. 2006;20(10):866.

PMID:
16599649
13.

Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.

Maltby N, Broe GA, Creasey H, Jorm AF, Christensen H, Brooks WS.

BMJ. 1994 Apr 2;308(6933):879-83.

14.

Double-blind placebo-controlled study of velnacrine in Alzheimer's disease.

Zemlan FP, Keys M, Richter RW, Strub RL.

Life Sci. 1996;58(21):1823-32.

PMID:
8637408
15.

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.

Farlow MR, Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL.

Neurology. 1998 Mar;50(3):669-77.

PMID:
9521254
16.

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.

Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT; Memantine MEM-MD-12 Study Group..

Curr Alzheimer Res. 2008 Feb;5(1):83-9.

PMID:
18288936
17.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
18.
19.

Supplemental Content

Support Center